Fineline Cube

Follow:
14483 Articles
Policy / RegulatoryR&D

China’s CDE Releases 69th Batch of Generic Chemical Reference Preparations for Public Review

CompanyDrug

Innovent Biologics’ GFH925 Earns Breakthrough Therapy Designation for KRASG12C CRC Treatment

CompanyDrug

CARsgen Therapeutics’ AB011 and Tecentriq Combo Gets NMPA Approval for Gastric Cancer Treatment

CompanyDrug

Fujian Cosunter Pharmaceutical Completes Enrollment in Phase II/III Trial for GST-HG171/Ritonavir

Company

BeiGene Reports Q1 2023 Financial Growth, Advances Pipeline with Global Expansion Plans

Policy / Regulatory

China’s Regulatory Bodies Unveil Guidelines to Strengthen Supervision of Medical Aesthetic Industry

CompanyDeals

Medisan Pharmaceutical Secures PPAR Agonist Technology from China Pharmaceutical University

Company

Meihua International Medical Expands with New Healthcare Industrial Park in Hainan

CompanyDrug

Ascletis Pharma’s ASC40 Meets Acne Treatment Goals in Phase II Trial

CompanyDrug

BDgene Technology’s BD111 Receives Tacit Approval for HSV-1 Keratitis Trial

CompanyDrug

SanReno Therapeutics Completes Dosing in Kidney Disease Trial for BION-1301

CompanyDrug

Qilu Pharmaceutical Launches First Generic Iressa in the US Market